ivacaftor

Italy

Drugs containing this active substance

  • KAFTRIO

    Kaftrio is a long-term treatment for patients with cystic fibrosis (CF) who have at least one CFTR gene mutation specific to responding to the drug. It helps lung cells function better, promoting breathing and improving lung function.

    Form: tablets, film-coated

    Active substance Dosage
    ivacaftor -
    tezacaftor -
    elexacaftor -

    ATC: R07AX32

    Manufacturer: VERTEX PHARMACEUTICALS (IRELAND) LIMITED

  • The drug is indicated for the treatment of cystic fibrosis (CF) in patients (children and adults) who have specific mutations in the CFTR gene. It works by helping abnormal proteins improve the movement of chloride through the cells.

    Form: tablets, film-coated

    Active substance Dosage
    ivacaftor -

    ATC: R07AX02

    Manufacturer: VERTEX PHARMACEUTICALS (IRELAND) LIMITED

  • It is used for the long-term treatment of cystic fibrosis in patients (aged 1 year and older) who have a specific genetic mutation called F508del.

    Form: tablets, film-coated

    Active substance Dosage
    ivacaftor -
    lumacaftor -

    ATC: R07AX30

    Manufacturer: VERTEX PHARMACEUTICALS (IRELAND) LIMITED

  • This medicine helps the lung cells work better in some patients with cystic fibrosis (CF). It is used to improve lung function and breathing, and it may help with weight gain or getting sick less often.

    Form: tablets, film-coated

    Active substance Dosage
    ivacaftor -
    tezacaftor -

    ATC: R07AX31

    Manufacturer: VERTEX PHARMACEUTICALS (IRELAND) LIMITED